Hatanaka Nobuyo | Division Of Social Communication System For Advanced Clinical Research The Institute Of Medical Scie
スポンサーリンク
概要
- HATANAKA Nobuyoの詳細を見る
- 同名の論文著者
- Division Of Social Communication System For Advanced Clinical Research The Institute Of Medical Scieの論文著者
関連著者
-
上 昌広
虎の門病院血液内科
-
上 昌広
国立がんセンター研究所 薬効試験部
-
上 昌広
東京大学医科学研究所探索医療ヒューマンネットワークシステム部門
-
上 昌広
虎の門病院血液科
-
Hatanaka Nobuyo
Division of Social Communication System for Advanced Clinical Research, the Institute of Medical Sci
-
上 昌広
国立がんセンター中央病院 造血幹細胞移植グループ
-
上 昌広
国立がんセ 中央病院 薬物療法部 幹細胞移植療法室
-
上 昌広
東京大学医科学研究所 探索医療ヒューマンネットワークシステム部門
-
Kami Masahiro
Division Of Medical Systems For Human Exploratory Network Institute Of Medical Science University Of
-
Kami Masahiro
The Department Of Hematology And Oncology Tokyo University
-
Miyagawa Kiyoshi
Department Of Developmental Biology And Oncology Research Institute For Radiation Biology And Medici
-
Kami Masahiro
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
上 昌広
東京大学医科学研究所先端医療社会コミュニケーションシステム社会連携研究部門
-
Matsumoto Shinichi
Division Of Social Communication System For Advanced Clinical Research The Institute Of Medical Scie
-
Kami Masahiro
Division Of Social Communication System For Advanced Clinical Research The Institute Of Medical Scie
-
Hatanaka Nobuyo
Division Of Social Communication System For Advanced Clinical Research The Institute Of Medical Scie
-
Tanaka Yuji
Division Of Endocrinology And Metabolism Department Of Internal Medicine National Defense Medical Co
-
Tanaka Yuji
Division Of Social Communication System For Advanced Clinical Research The Institute Of Medical Scie
-
Yamaguchi Takuhiro
Biostatistics Tohoku University Graduate School Of Medicine
-
TAKITA Morihito
Division of Social Communication System for Advanced Clinical Research, The Institute of Medical Sci
-
Takita Morihito
Division Of Social Communication System For Advanced Clinical Research The Institute Of Medical Scie
著作論文
- Why Do Japan's Advanced Medical Treatments Never Get Ahead?
- Development of a novel scale to assess the quality of life in type 1 diabetic patients for beta cell replacement therapy